| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/17/2012 | US20120121645 Supralingual vaccines and applicators |
| 05/17/2012 | US20120121644 Sticky soft gel for treating poultry |
| 05/17/2012 | US20120121643 Engineered listeria and methods of use thereof |
| 05/17/2012 | US20120121640 OX40/TRAIL Fusion Proteins |
| 05/17/2012 | US20120121639 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 05/17/2012 | US20120121638 Polypeptide Derived From Enterococcus And Its Use For Vaccination |
| 05/17/2012 | US20120121636 Tat-Based Vaccine Compositions and Methods of Making and Using Same |
| 05/17/2012 | US20120121634 Soluble pd-1 variants, fusion constructs, and uses thereof |
| 05/17/2012 | US20120121631 Polyvalent vaccine |
| 05/17/2012 | US20120121630 Recombinant ectodomain expression of herpes simplex virus glycoproteins in yeast |
| 05/17/2012 | US20120121629 New human rotavirus vaccine strains and diagnostics |
| 05/17/2012 | US20120121628 Lipidated polyepitope vaccines |
| 05/17/2012 | US20120121627 Peptides for active anti-cytokine immunization |
| 05/17/2012 | US20120121624 Hepatitis c virus ns3 protease inhibitors |
| 05/17/2012 | US20120121623 Novel antipathogenic peptides |
| 05/17/2012 | US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/17/2012 | US20120121621 Synergistic prebiotic compositions |
| 05/17/2012 | US20120121619 Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate |
| 05/17/2012 | US20120121618 Predicting And Treating Prostate Cancer |
| 05/17/2012 | US20120121617 Promoters for recombinant viral expression |
| 05/17/2012 | US20120121616 Immune balance-regulating agent |
| 05/17/2012 | US20120121611 Method of treating autoimmune disease with mesenchymal stem cells |
| 05/17/2012 | US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 05/17/2012 | US20120121603 Compositions And Methods For The Therapy And Diagnosis Of Influenza |
| 05/17/2012 | US20120121602 Novel proteins |
| 05/17/2012 | US20120121601 Mammalian receptor proteins; related reagents and methods |
| 05/17/2012 | US20120121598 Compositions containing antibodies for treating cd5+hla-dr+b or t cell related diseases |
| 05/17/2012 | US20120121592 Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells |
| 05/17/2012 | US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 |
| 05/17/2012 | US20120121585 SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES |
| 05/17/2012 | US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/17/2012 | US20120121578 Methods of using immunoglobulin aggregates |
| 05/17/2012 | US20120121574 Antimicrobial, antiviral, anticancer and immunomodulatory peptides and uses therefore |
| 05/17/2012 | US20120121572 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity |
| 05/17/2012 | US20120121563 Specialized nutritional formula for adult patients with gastrointestinal intolerance containing probiotics |
| 05/17/2012 | US20120121562 Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients |
| 05/17/2012 | US20120121561 Dry whole milk preparations containing probiotic micro-organisms |
| 05/17/2012 | US20120121556 Methods of using regenerative cells to promote wound healing |
| 05/17/2012 | US20120121554 Hmg-coa secondary metabolites and uses thereof |
| 05/17/2012 | US20120121552 Methods for purifying hematopoietic stem cells |
| 05/17/2012 | US20120121551 Compositions and methods for immunostimulatory rna oligonucleotides |
| 05/17/2012 | US20120121541 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 05/17/2012 | US20120121539 Programming Of Cells for Tolerogenic Therapies |
| 05/17/2012 | US20120121538 Combined measles-malaria vaccine |
| 05/17/2012 | US20120121527 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARy TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF |
| 05/16/2012 | EP2453010A1 Neural progenitor cells derived from embryonic stem cells |
| 05/16/2012 | EP2453009A1 Methods of organ regeneration |
| 05/16/2012 | EP2452939A2 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist |
| 05/16/2012 | EP2451843A1 Diagnosis and treatment of autoimmune demyelinating diseases |
| 05/16/2012 | EP2451813A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 05/16/2012 | EP2451811A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use |
| 05/16/2012 | EP2451773A2 Novel polymorphic form of teriflunomide salts |
| 05/16/2012 | EP2303251B1 New combination for use in the treatment of inflammatory disorders |
| 05/16/2012 | EP1969011B1 Preparation for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 05/16/2012 | EP1883415B1 Water insoluble helichrysum extract, process for preparing the same and uses thereof |
| 05/16/2012 | EP1864665B1 Immunosuppressive agent comprising a heterocyclic compound as active ingredient |
| 05/16/2012 | CN102459577A 适合临床应用于免疫介导性疾病的、具有增强型抑制功能的调节性t细胞的体外扩增方法 Suitable for clinical application of immune-mediated diseases, with enhanced suppression function of regulatory t-cells in vitro amplification methods |
| 05/16/2012 | CN102459323A 重组产生的过敏原 Recombinantly produced allergens |
| 05/16/2012 | CN102459270A Janus激酶3的哌啶抑制剂 Janus kinase 3 inhibitor piperidine |
| 05/16/2012 | CN102459261A 用于治疗变性和炎性疾病的新化合物 The new compounds for treating degenerative and inflammatory diseases for |
| 05/16/2012 | CN102459253A Oxazole substituted indazoles as pi3-kinase inhibitors |
| 05/16/2012 | CN102459244A 喹唑啉二酮衍生物、其制备及其多种治疗用途 Quinazoline dione derivatives, their preparation and their therapeutic uses multiple |
| 05/16/2012 | CN102459224A 5-alkynyl-pyridines |
| 05/16/2012 | CN102459206A Oxadiazole derivatives |
| 05/16/2012 | CN102459198A Crystals |
| 05/16/2012 | CN102459187A Janus激酶抑制化合物和方法 Janus kinase inhibiting compounds and methods |
| 05/16/2012 | CN102459179A Pyridinone antagonists of alpha-4 integrins |
| 05/16/2012 | CN102458465A Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp) |
| 05/16/2012 | CN102458446A Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma |
| 05/16/2012 | CN102458443A 细胞周期蛋白依赖性激酶抑制剂及使用方法 Cyclin-dependent kinase inhibitors and methods of use |
| 05/16/2012 | CN102458428A Nfat signal inhibitor and calcineurin inhibitor |
| 05/16/2012 | CN102458410A Methods of treatment for solid tumors |
| 05/16/2012 | CN102458383A Opioid receptors stimulating compounds (thymoquinone, nigella sativa) and food allergy |
| 05/16/2012 | CN102453689A Lactobacillus plantarum strain producing extracellular polysaccharide, and application thereof |
| 05/16/2012 | CN102453661A Formula of health-care wine and making method thereof |
| 05/16/2012 | CN102453657A Method for preparing astragalus medicinal liquor |
| 05/16/2012 | CN102453089A Preparation and application of recombinant consensus interferon mutant polyethylene glycol conjugate |
| 05/16/2012 | CN102453086A Natural immunomodulation protein TRIM38 and its purpose |
| 05/16/2012 | CN102453016A N-(2,6-dibenzyloxy benzoyl)-N'-substituted urea compound and preparation method and application thereof |
| 05/16/2012 | CN102452916A New aromatic polyketones, extraction method and application thereof |
| 05/16/2012 | CN102451394A Preparation method for Chinese herbal prescription used for treating Henoch-Schonlein purpura nephritis |
| 05/16/2012 | CN102451355A Chinese medicinal formula for treating eczema ani |
| 05/16/2012 | CN102451351A Recipe for immunity regulation medicine |
| 05/16/2012 | CN102451350A Formula of medicament for enhancing immunity |
| 05/16/2012 | CN102451346A Medicinal liquor for diminishing inflammation, and preparation method thereof |
| 05/16/2012 | CN102451293A Traditional Chinese medicine formula used for treating allergic rhinitis |
| 05/16/2012 | CN102451281A Chinese medicinal formula for treating eczema ani |
| 05/16/2012 | CN102451219A Fermented soya bean active substance and preparation method thereof |
| 05/16/2012 | CN102451215A Extraction technology of gypenoside |
| 05/16/2012 | CN102451207A Technology of extracting phenols from puna chicory |
| 05/16/2012 | CN102451189A Donkey-hide gelatin injection and preparation method thereof |
| 05/16/2012 | CN102451182A Preparation method of compound pseudoephedrine hydrochloride capsule |
| 05/16/2012 | CN102451179A Enteric solid preparation containing lycopene, resveratrol or melatonin and preparation method of enteric solid preparation |
| 05/16/2012 | CN102451169A Loratadine lyophilized tablets and preparation method thereof |
| 05/16/2012 | CN102451167A H1 accepter antagonist oral cavity disintegrating tablet and preparation method thereof |
| 05/16/2012 | CN102451163A Polyporus polysaccharide dispersible tablets, and preparation method thereof |
| 05/16/2012 | CN102450653A Animal spleen dry powder |
| 05/16/2012 | CN101912453B Medicinal composition with anti-inflammatory and analgesic effects and preparation method and application thereof |
| 05/16/2012 | CN101897766B Anti-inflammatory and analgesic medicine composition as well as preparation method and application thereof |
| 05/16/2012 | CN101696243B Human genetic engineering antibody TRD 109 as well as preparation method and application thereof |